Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
Influenza virus hemagglutinin (HA) N-glycans play important regulatory roles in the control of virus virulence, antigenicity, receptor-binding specificity, and viral escape from the immune response. Considered essential for controlling innate and adaptive immune responses against influenza virus infections, dendritic cells (DCs) trigger proinflammatory and adaptive immune responses in hosts. In this study, we engineered Chinese hamster ovary (CHO) cell lines expressing recombinant HA from pandemic H1, H5, and H7 influenza viruses. rH1HA, rH5HA, and rH7HA were obtained as wild-type proteins or in the presence of kifunensine (KIF) or further with endo-β-N-acetylglucosaminidase-treated KIF (KIF+E) to generate single-N-acetylglucosamine (GlcNAc) N-glycans consisting of (i) terminally sialylated complex-type N-glycans, (ii) high-mannose-type N-glycans, and (iii) single-GlcNAc-type N-glycans. Our results show that high-mannose-type and single-GlcNAc-type N-glycans, but not complex-type N-glycans, are capable of inducing more active hIL12 p40, hIL12 p70, and hIL-10 production in human DCs. Significantly higher HLA-DR, CD40, CD83, and CD86 expression levels, as well reduced endocytotic capacity in human DCs, were noted in the high-mannose-type rH1HA and single-GlcNAc-type rH1HA groups than in the complex-type N-glycan rH1HA group. Our data indicate that native avian rHA proteins (H5N1 and H7N9) are more immunostimulatory than human rHA protein (pH1N1). The high-mannose-type or single-GlcNAc-type N-glycans of both avian and human HA types are more stimulatory than the complex-type N-glycans. HA-stimulated DC activation was accomplished partially through a mannose receptor(s). These results provide more understanding of the contribution of glycosylation of viral proteins to the immune responses and may have implications for vaccine development.



Influenza viruses trigger seasonal epidemics or pandemics with mild-to-severe consequences for human and poultry populations. DCs are the most potent professional antigen-presenting cells, which play a crucial role in the link between innate and adaptive immunity. In this study, we obtained stable-expression CHO cells to produce rH1HA, rH5HA, and rH7HA proteins containing distinct N-glycan patterns. These rHA proteins, each with a distinct N-glycan pattern, were used to investigate interactions with mouse and human DCs. Our data indicate that native avian rHA proteins (H5N1 and H7N9) are more immunostimulatory than human rHA protein (pH1N1). High-mannose-type and single-GlcNAc-type N-glycans were more effective than complex-type N-glycans in triggering mouse and human DC activation and maturation. We believe these results provide some useful information for influenza vaccine development regarding how influenza virus HA proteins with different types of N-glycans activate DCs.
Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan.
Wen-Chun
WC
Liu
Department of Medical Research, National Taiwan University Hospital, Taiwan.
Yu-Li
YL
Lin
Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Maureen
M
Spearman
Department of Medical Research, National Taiwan University Hospital, Taiwan.
Pei-Yun
PY
Cheng
Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Michael
M
Butler
Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan scwu@mx.nthu.edu.tw.|Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan.
Suh-Chin
SC
Wu
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D015703:Antigens, CD / Q000235:genetics; D051940:B7-2 Antigen / Q000235:genetics; D001717:Birds; D019013:CD40 Antigens / Q000235:genetics; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D003713:Dendritic Cells / Q000276:immunology* / Q000502:physiology; D006684:HLA-DR Antigens / Q000235:genetics; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics; D053118:Influenza A Virus, H1N1 Subtype / Q000737:chemistry / Q000235:genetics; D053124:Influenza A Virus, H5N1 Subtype / Q000737:chemistry / Q000235:genetics; D064766:Influenza A Virus, H7N9 Subtype / Q000737:chemistry / Q000235:genetics; D005585:Influenza in Birds / Q000821:virology; D007251:Influenza, Human / Q000821:virology; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology; D018664:Interleukin-12 / Q000235:genetics / Q000276:immunology; D053762:Interleukin-12 Subunit p40 / Q000235:genetics / Q000276:immunology; D008562:Membrane Glycoproteins / Q000235:genetics; D058873:Pandemics; D011994:Recombinant Proteins / Q000276:immunology / Q000378:metabolism; D000097802:CD83 Antigen
D000470:Alkaloids; D015703:Antigens, CD; D051940:B7-2 Antigen; D019013:CD40 Antigens; D006684:HLA-DR Antigens; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007136:Immunoglobulins; D016753:Interleukin-10; D018664:Interleukin-12; D053762:Interleukin-12 Subunit p40; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D000097802:CD83 Antigen; C497964:CD86 protein, human; C508609:IL10 protein, human; C500879:IL12B protein, human; C065629:kifunensine